These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20111691)

  • 1. Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP).
    Segala J; Engelman DM; Reshetnyak YK; Andreev OA
    Int J Mol Sci; 2009 Aug; 10(8):3478-87. PubMed ID: 20111691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.
    Andreev OA; Dupuy AD; Segala M; Sandugu S; Serra DA; Chichester CO; Engelman DM; Reshetnyak YK
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7893-8. PubMed ID: 17483464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family of pH (low) insertion peptides for tumor targeting.
    Weerakkody D; Moshnikova A; Thakur MS; Moshnikova V; Daniels J; Engelman DM; Andreev OA; Reshetnyak YK
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5834-9. PubMed ID: 23530249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes.
    Adochite RC; Moshnikova A; Golijanin J; Andreev OA; Katenka NV; Reshetnyak YK
    Mol Imaging Biol; 2016 Oct; 18(5):686-96. PubMed ID: 27074841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
    Saccomano M; Dullin C; Alves F; Napp J
    Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.
    Tapmeier TT; Moshnikova A; Beech J; Allen D; Kinchesh P; Smart S; Harris A; McIntyre A; Engelman DM; Andreev OA; Reshetnyak YK; Muschel RJ
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9710-5. PubMed ID: 26195776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
    Svoronos AA; Engelman DM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo.
    Golijanin J; Amin A; Moshnikova A; Brito JM; Tran TY; Adochite RC; Andreev GO; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK; Golijanin D
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11829-11834. PubMed ID: 27688767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
    Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM
    Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.
    Reshetnyak YK; Yao L; Zheng S; Kuznetsov S; Engelman DM; Andreev OA
    Mol Imaging Biol; 2011 Dec; 13(6):1146-56. PubMed ID: 21181501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pHLIP peptide targets nanogold particles to tumors.
    Yao L; Daniels J; Moshnikova A; Kuznetsov S; Ahmed A; Engelman DM; Reshetnyak YK; Andreev OA
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):465-70. PubMed ID: 23267062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Far-red/near-infrared fluorescence light-up probes for specific in vitro and in vivo imaging of a tumour-related protein.
    Chen C; Hua Y; Hu Y; Fang Y; Ji S; Yang Z; Ou C; Kong D; Ding D
    Sci Rep; 2016 Mar; 6():23190. PubMed ID: 26984064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cells targeting with genetically engineered constructs based on a pH-dependent membrane insertion peptide and fluorescent protein.
    Frolova AY; Pakhomov AA; Kakuev DL; Sungurova AS; Deyev SM; Martynov VI
    Biochem Biophys Res Commun; 2022 Jul; 612():141-146. PubMed ID: 35525198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
    Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
    Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant.
    Vasquez-Montes V; Gerhart J; King KE; Thévenin D; Ladokhin AS
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):534-543. PubMed ID: 29138065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Situ Self-Assembled Nanofibers Precisely Target Cancer-Associated Fibroblasts for Improved Tumor Imaging.
    Zhao XX; Li LL; Zhao Y; An HW; Cai Q; Lang JY; Han XX; Peng B; Fei Y; Liu H; Qin H; Nie G; Wang H
    Angew Chem Int Ed Engl; 2019 Oct; 58(43):15287-15294. PubMed ID: 31402550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane.
    Reshetnyak YK; Andreev OA; Segala M; Markin VS; Engelman DM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15340-5. PubMed ID: 18829441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.
    Kimbrough CW; Khanal A; Zeiderman M; Khanal BR; Burton NC; McMasters KM; Vickers SM; Grizzle WE; McNally LR
    Clin Cancer Res; 2015 Oct; 21(20):4576-85. PubMed ID: 26124201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.
    Yao L; Daniels J; Wijesinghe D; Andreev OA; Reshetnyak YK
    J Control Release; 2013 May; 167(3):228-37. PubMed ID: 23416366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.